ANI Pharma (ANIP) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LVS
9. LRCX
10. MRK

Go back to ANI Pharma (ANIP) Tops Q1 EPS by 4c

ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance

May 8, 2018 8:30 AM EDT

BAUDETTE, Minn., May 8, 2018 /PRNewswire/ --

For the first quarter 2018:

Net revenues of $46.5 million, an increase of 27% as compared to the same period in 2017 GAAP net income of $2.3 million and diluted GAAP earnings per share of $0.19 Adjusted non-GAAP EBITDA of $21.8 million Adjusted non-GAAP diluted earnings per share of $1.32

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported its financial results for the three months ended March 31, 2018 and reaffirmed its 2018 financial guidance. The Company will host its earnings... More